1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects

Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association

Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors

A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia

Genetic components in factor VIII receptors for individual and genotype-modeled hemophilia A treatment

Engineered suppressor tRNAs as a novel correction approach for recurrent hemophilia A-causing nonsense mutations

A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms

An engineered factor X variant as a novel by-passing agent for hemophilia

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes

The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A

The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms

Translation termination codons in protein synthesis and disease

Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output

The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones

Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity

The carboxyl-terminal region of coagulation serine proteases: A matter of cut and change

Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes

A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia

Editorial Board Member della rivista International Journal of Biochemistry & Cell Biology

Editorial Board Member della rivista DNA and Cell Biology